{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:11:35Z","timestamp":1770063095834,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V105B-001, V106B-001, and V107C-081"],"award-info":[{"award-number":["V105B-001, V106B-001, and V107C-081"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Szu-Yuan Research Foundation of Internal Medicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3184-8","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T21:49:38Z","timestamp":1529012978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia"],"prefix":"10.1186","volume":"18","author":[{"given":"Pei-Shan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Der","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"issue":"986","key":"3184_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/pgmj.2007.064683","volume":"83","author":"M Melzer","year":"2007","unstructured":"Melzer M, Toner R, Lacey S, Bettany E, Rait G. Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes. Postgrad Med J. 2007;83(986):773\u20136.","journal-title":"Postgrad Med J"},{"issue":"3","key":"3184_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/ajg.2011.387","volume":"107","author":"YK Sung","year":"2012","unstructured":"Sung YK, Lee JK, Lee KH, Lee KT, Kang CI. The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. Am J Gastroenterol. 2012;107(3):473\u201383.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"3184_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1572-0241.2007.01095.x","volume":"102","author":"CC Lee","year":"2007","unstructured":"Lee CC, Chang IJ, Lai YC, Chen SY, Chen SC. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol. 2007;102(3):563\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"3184_CR4","first-page":"172","volume":"74","author":"C Royo-Cebrecos","year":"2017","unstructured":"Royo-Cebrecos C, Gudiol C, Garc\u00eda J, Tubau F, Laporte J, Ardanuy C, Antonio M, Marin M, Gornals JB, Carratal\u00e0 J. Characteristics, aetiology, antimicrobial resistance and outcomes of bacteraemic cholangitis in patients with solid tumours: a prospective cohort study. J Inf Secur. 2017;74(2):172\u20138.","journal-title":"J Inf Secur"},{"issue":"10","key":"3184_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmi.2017.02.027","volume":"23","author":"Y Tagashira","year":"2017","unstructured":"Tagashira Y, Sakamoto N, Isogai T, Hikone M, Kosaka A, Chino R, Higuchi M, Uehara Y, Honda H. Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study. Clin Microbiol Infect. 2017;23(10):740\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"3184_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jhbp.518","volume":"25","author":"H Gomi","year":"2018","unstructured":"Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):3\u201316.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"12","key":"3184_CR7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/archinte.1979.03630490016008","volume":"139","author":"AM Bourgault","year":"1979","unstructured":"Bourgault AM, England DM, Rosenblatt JE, Forgacs P, Bieger RC. Clinical characteristics of anaerobic bactibilia. Arch Intern Med. 1979;139(12):1346\u20139.","journal-title":"Arch Intern Med"},{"issue":"2","key":"3184_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133\u201364.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3184_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.diagmicrobio.2014.10.002","volume":"81","author":"HA Kim","year":"2015","unstructured":"Kim HA, Chung DR, Yeom JS, Ki HK, Cheong HS, Son JS, Lee JS, Moon SY, Lee SS, Lee JA, et al. Anti-anaerobic coverage is not necessary for Klebsiella pneumoniae liver abscess: a propensity score-matched cohort study. Diagn Microbiol Infect Dis. 2015;81(1):60\u20135.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"3184_CR10","first-page":"83","volume":"19","author":"K Kapoor","year":"1999","unstructured":"Kapoor K, Chandra M, Nag D, Paliwal JK, Gupta RC, Saxena RC. Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res. 1999;19(3):83\u20138.","journal-title":"Int J Clin Pharmacol Res"},{"issue":"3","key":"3184_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijantimicag.2016.06.015","volume":"48","author":"G Levy Hara","year":"2016","unstructured":"Levy Hara G, Kanj SS, Pagani L, Abbo L, Endimiani A, Wertheim HFL, Am\u00e1bile-Cuevas C, Tattevin P, Mehtar S, Lopes Cardoso F, et al. Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the antimicrobial stewardship and resistance working groups of the International Society of Chemotherapy. Int J Antimicrob Agents. 2016;48(3):239\u201346.","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"3184_CR12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","volume":"137","author":"ND Friedman","year":"2002","unstructured":"Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791\u20137.","journal-title":"Ann Intern Med"},{"key":"3184_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fmicb.2015.00122","volume":"9","author":"YT Lin","year":"2015","unstructured":"Lin YT, Wang YP, Wang FD, Fung CP. Community-onset Klebsiella pneumoniae pneumonia in Taiwan: clinical features of the disease and associated microbiological characteristics of isolates from pneumonia and nasopharynx. Front Microbiol. 2015;9:122.","journal-title":"Front Microbiol"},{"issue":"3","key":"3184_CR14","first-page":"279","volume":"41","author":"Guidelines for antimicrobial therapy of intra-abdominal infections in adults","year":"2008","unstructured":"Guidelines for antimicrobial therapy of intra-abdominal infections in adults. J Microbiol Immunol Infect. 2008;41(3):279\u201381.","journal-title":"J Microbiol Immunol Infect"},{"key":"3184_CR15","first-page":"M100","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement","author":"CLSI","year":"2014","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document. Wayne, PA: Clinical and Laboratory Standards Institute; 2014. p. M100\u2013S24."},{"issue":"6","key":"3184_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jac\/35.6.855","volume":"35","author":"JJ Sung","year":"1995","unstructured":"Sung JJ, Lyon DJ, Suen R, Chung SC, Co AL, Cheng AF, Leung JW, Li AK. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: a randomized, controlled clinical trial. J Antimicrob Chemother. 1995;35(6):855\u201364.","journal-title":"J Antimicrob Chemother"},{"issue":"26","key":"3184_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","volume":"343","author":"CJ Donskey","year":"2000","unstructured":"Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, Hutton-Thomas RA, Whalen CC, Bonomo RA, Rice LB. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925\u201332.","journal-title":"N Engl J Med"},{"issue":"11","key":"3184_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nri3535","volume":"13","author":"CG Buffie","year":"2013","unstructured":"Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013;13(11):790\u2013801.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"3184_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/502408","volume":"25","author":"U Stiefel","year":"2004","unstructured":"Stiefel U, Pultz NJ, Helfand MS, Donskey CJ. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect Control Hosp Epidemiol. 2004;25(5):373\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"3184_CR20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1086\/428090","volume":"191","author":"NJ Pultz","year":"2005","unstructured":"Pultz NJ, Stiefel U, Subramanyan S, Helfand MS, Donskey CJ. Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus. J Infect Dis. 2005;191(6):949\u201356.","journal-title":"J Infect Dis"},{"key":"3184_CR21","doi-asserted-by":"publisher","unstructured":"Doi A, Morimoto T, Iwata K. Shorter Duration of Aimntibiotic Treatment for Acute Bacteraemic Cholangitis with Successful Biliary Drainage:A Retrospective Cohort Study. Clin Microbiol Infect 2018. \n                    https:\/\/doi.org\/10.1016\/j.cmi.2018.01.021\n                    \n                  .","DOI":"10.1016\/j.cmi.2018.01.021"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3184-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3184-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T19:05:17Z","timestamp":1560539117000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3184-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3184"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3184-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]},"assertion":[{"value":"9 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institution Review Board of Taipei Veterans General.Hospital. The informed consent was waived because of the retrospective nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"277"}}